- Home
- /
- Treatment
- /
- Page 94
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Cysteamine | Neuronal ceroid lipofuscinoses (Batten disease) | Raptor Pharmaceuticals, Inc.;9 Commercial Blvd., Suite 200;Novato, California, 94949 | August 6, 2008 | |
Intravenous immune globulin (human) 10% | Stiff-person syndrome | Octapharma USA, Inc.;121 River Street;Hoboken, New Jersey, 07030 | July 31, 2008 | |
Deferiprone | Friedreich Ataxia | ApoPharma, Inc.;200 Barmac Drive, M9L 2Z7; | July 31, 2008 | |
4-[1]benzofuro[3,2-d]pyrimidin-4-yl-N-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbothioamide | Glioblastoma | SuperGen, Inc.;4140 Dublin Blvd;Dublin, California, 94568 | July 30, 2008 | |
Anthrax immune globulin (human) | Toxemia associated with inhalational anthrax | Cangene Corp. - Emergent Biosolutions;155 Innovation Drive, R3T 5Y3; | July 29, 2008 | |
Recombinant disintegrin and metalloprotease with thrombospondin type 1 motifs | Thrombotic thrombocytopenic purpura including its congential, acquired idiopathic, and secondary forms | Baxalta US Inc.;1 Baxter Way;Westlake Village, California, 91362 | July 29, 2008 | |
Anthrax immune globulin (human) | Anthrax | Cangene Corp. - Emergent Biosolutions;155 Innovation Drive, R3T 5Y3;Winnipeg, MB | July 29, 2008 | |
Recombinant disintegrin and metalloprotease with thrombospondin type 1 motifs | Idiopathic thrombocytopenic purpura | Baxalta US Inc.;1 Baxter Way;Westlake Village, California, 91362 | July 29, 2008 | |
3-fluoro-5-[5-(2-menthyl-thiazol-4-ylethylnyl)-pyridin-2-yl]-benzonitrile dihydrochloride | Behavioral abnormalities associated with fragile X syndrome | Seaside Therapeutics;840 Memorial Drive;Cambridge, Massachusetts, 02139 | July 28, 2008 | |
Afamelanotide | Erythropoietic porphyrias | Clinuvel Inc.;40 Worth Street, Suite 1053;New York, New York, 10013 | July 17, 2008 | |
[Nle4, D-Phe7]-a-melanocyte stimulating hormone | Erythropoietic porphyrias | Clinuvel Inc.;40 Worth Street, Suite 1053;New York, NY, 10013 | July 17, 2008 | |
Mx-dnG1 | Soft tissue sarcoma | Epeius Biotechnologies Corporation;475 Huntington Drive;San Marino, California, 91108 | June 24, 2008 | |
Mx-dnG1 | Pediatric osteosarcoma | Epeius Biotechnologies Corporation;475 Huntington Drive;San Marino, California, 91108 | June 24, 2008 | |
Carbon monoxide | For use in the reduction of the incidence and severity of delayed graft function in patients undergoing solid organ transplanation | INO Therapeutics;Perryville III Corporate Park, P. O. Box 9001;Hampton, New Jersey, 08827 | June 24, 2008 | |
Cicletanine hydrochloride | Treatment for pulmonary arterial hypertension | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 | June 24, 2008 | |
Cardiotrophin-1 | To protect the liver from ischemia-reperfusion injury inherent to the procedure of transplantation | Digna Biotech, S.L.;Avenids Carlos III de Noble, Pamplona (Navarra); | June 24, 2008 | |
Alicaforsen | Pouchitis | Atlantic Healthcare Limited;Maple House, Halsted, Essex CO9 4BB; | June 24, 2008 | |
Recombinant adeno-associated virus retinal pigment epithelium gene vector AAV2-hRPE65v2 | Leber congenital amaurosis | Spark Therapeutics, Inc.;3737 Market Street, Suite 1300;Philadelphia, Pennsylvania, 19104 | June 24, 2008 | |
4-[[[4-(4-Chlorophenoxy)phenyl]sulfonyl]-methyl] tetrahydro-N-hydroxy-2H-pyran-4-carboxamide | Prophylaxis of organ rejection in patients receiving allogeneic liver transplants | Conatus Pharmaceuticals, Inc.;4365 Executive Drive;San Diego, California, 92121 | June 18, 2008 | |
Elacytarabine | Acute myeloid leukemia | Clavis Pharma ASA;Parkveien 53 B; | June 18, 2008 | |
Cenersen | Metastatic Melanoma | Eleos, Inc.;1001 Twelve Oaks Center Drive, Suite 1002;Wayzata, Minnesota, 55391 | June 18, 2008 | |
Azacitidine | Acute myeloid leukemia | Celgene Corporation;9900 W. 109th Street, Suite 300;Overland Park, Kansas, 66210 | June 18, 2008 | |
Bupivacaine | Relief of persistent pain associated with postherpetic neuralgia | DURECT Corporation;10260 Bubb Road;Cupertino, California, 95014 | June 18, 2008 | |
2 dimethylbutyrate | Beta-thalassemia | HemaQuest Pharmaceuticals, Inc.;1001 Fourth Avenue, Suite 3317;Seattle, Washington, 98154 | June 18, 2008 | |
Blinatumomab | Acute lymphoblastic leukemia | Amgen, Inc.;One Amgen Center Dr., Mail Stop 17-2-A;Thousand Oaks, California, 91320 | May 16, 2008 |